Report Description
The global helicobacter pylori diagnostics market size is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the improved cost-effectiveness of diagnosis of infection and rising demand for personalized antibiotic therapy.
Helicobacter pylori, also known as an aerobic gram-negative bacteria, is commonly found in stomach. Although stomach ecology is balanced by this bacteria, still it can cause infection to the inner stomach lining. The bacteria acts as a causative agent for gastric ulcers, gastritis, stomach cancer, infection in the small intestine, and duodenal ulcers. This generates demand for diagnostic methods for helicobacter pylori infection. In case of positive diagnosis of ulcers, antibiotic treatment is generally given to patients for 10 to 14 days.
In 1994, the International Agency for Research on Cancer categorized helicobacter pylori as a carcinogen. Although the exact mode of transmission of this infection remains uncertain, it is suggested that the infection can be transmitted from one person to other through fecal-oral route. The helicobacter pylori infection, which is mostly seen in childhood has no any specific symptoms. This infection is highly prevalent in developing nations due to some major factors such as dense population, lack of water supply, poor personal hygiene, and poor sanitation.
Market Trends, Drivers, Restraints, and Opportunities
- Rising awareness about the infection and growing governments’ programs for the healthcare development especially in developing countries are key factors responsible for driving market growth.
- Availability of personalized antibiotic treatment, affordable, and cost-effective diagnosis are drivers for the helicobacter pylori diagnostics market.
- Rapid development of advanced technology for diagnostics and rising preference for early detection of the infection are major factors boosting the market growth.
- Easy accessibility of point-of-care testing as well as availability of several invasive and non-invasive devices are anticipated to propel the growth of the market.
- Lack of awareness about benefits of the testing and unavailability of skilled professionals are projected to hamper the market growth.
Scope of the Report
The report on the global helicobacter pylori diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Helicobacter Pylori Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2020
|
Historic Data
|
2018–2019
|
Forecast Period
|
2021–2028
|
Segmentation
|
Technology (Immunoassays, POC, and Molecular Diagnostics) and End-users (Hospitals, Diagnostics Laboratories, and Clinics)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Thermo Fisher Scientific; Biohit; Quest Diagnostics; Meridian Bioscience; Bio-Rad Laboratories; Alpha Laboratories; F. Hoffmann-La Roche; Coris BioConcept; Certest Biotec; and Epitope Diagnostics
|
Helicobacter Pylori Diagnostics Market Segment Insights
Immunoassay segment to account for a key share
Based on technology, the global helicobacter pylori diagnostics market is divided into immunoassays, POC, and molecular diagnostics. The immunoassay segment accounted for a large market share in 2019 and is projected to expand at a rapid growth rate during the forecast period. For detecting of antibodies, many technologies are used and the enzyme immunoassays is one of the most widely adopted technology for the same purpose. On the other hand, the POC segment is expected to register substantial growth during the forecast period owing to wide adoption of the technique for helicobacter pylori diagnostics. Meanwhile, the molecular diagnostics accounted for the second largest market share in 2019 due to its high accuracy and improved testing result.
Hospitals segment to hold a major market share
On the basis of end-users, the market is divided into hospitals, diagnostics laboratories, and clinics. In 2019, the hospitals segment held a major market share and the trend is likely to continue during the forecast period. The segment growth can be attributed to ease of accessibility of doctors and medical staffs who are expert in disease presentation of related diseases such as gastritis, infections to small intestine, duodenal ulcers, gastric ulcers, and stomach cancer.
The diagnostic laboratories segment, however, is anticipated to show a fast CAGR during the forecast period owing to efficient and specialized detection of infection in the specialized laboratories. Moreover, the rising adoption of the testing process of the infection in diagnostic laboratories in a search of finding advanced drugs and techniques for the treatment present another key driver for the segment growth. In 2019, the combined share of hospitals and diagnostics laboratories represented more than 80% share of the total market.
North America is projected to exhibit a robust CAGR
In terms of regions, the global helicobacter pylori diagnostics market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2019 and is projected to exhibit a robust CAGR during the forecast period owing to better economy and healthcare infrastructural development. Moreover, the presence of key global players in the region especially in the US is another crucial factor for the regional market expansion. On the other hand, the market in Asia Pacific is anticipated to register a fast CAGR during the forecast period owing to increasing rate of population growth and rising occurrence of helicobacter pylori infections in the region.
Segments
Segments Covered in the Report
The global helicobacter pylori diagnostics market has been segmented on the basis of
Technology
- Immunoassays
- POC
- Molecular Diagnostics
End-users
- Hospitals
- Diagnostics Laboratories
- Clinics
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Thermo Fisher Scientific
- Biohit, Quest Diagnostics
- Meridian Bioscience
- Bio-Rad Laboratories
- Alpha Laboratories
- F. Hoffmann-La Roche
- Coris BioConcept
- Certest Biotec
- Epitope Diagnostics
Competitive Landscape
Some of the key players competing in the market are Thermo Fisher Scientific, Biohit, Quest Diagnostics, Meridian Bioscience, Bio-Rad Laboratories, Alpha Laboratories, F. Hoffmann-La Roche, Coris BioConcept, Certest Biotec, and Epitope Diagnostics.
These three major players such as Bio-Rad Laboratories, Quest Diagnostics, and Thermo Fisher Scientific accounted for a highest share of market in 2019 owing to wider geographical presence and broad product portfolio. The key players are constantly adopting many strategies such as mergers and acquisitions, regional expansions, strategic partnerships, and new product development to expand their market positions.
Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Helicobacter Pylori Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Helicobacter Pylori Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Helicobacter Pylori Diagnostics Market - Supply Chain
4.5. Global Helicobacter Pylori Diagnostics Market Forecast
4.5.1. Helicobacter Pylori Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Helicobacter Pylori Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Helicobacter Pylori Diagnostics Market Absolute $ Opportunity
5. Global Helicobacter Pylori Diagnostics Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
5.3.1. Hospitals
5.3.2.
Diagnostics Laboratories
5.3.3.
Clinics
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Helicobacter Pylori Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
7. North America Helicobacter Pylori Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
7.4.1. Hospitals
7.4.2.
Diagnostics Laboratories
7.4.3.
Clinics
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Helicobacter Pylori Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
8.4.1. Hospitals
8.4.2.
Diagnostics Laboratories
8.4.3.
Clinics
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
9. Europe Helicobacter Pylori Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
9.4.1. Hospitals
9.4.2.
Diagnostics Laboratories
9.4.3.
Clinics
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Helicobacter Pylori Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
10.4.1. Hospitals
10.4.2.
Diagnostics Laboratories
10.4.3.
Clinics
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Helicobacter Pylori Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
11.4.1. Hospitals
11.4.2.
Diagnostics Laboratories
11.4.3.
Clinics
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Helicobacter Pylori Diagnostics Market: Market Share Analysis
12.2. Helicobacter Pylori Diagnostics Distributors and Customers
12.3. Helicobacter Pylori Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Thermo Fisher Scientific
12.4.2.
Biohit, Quest Diagnostics
12.4.3.
Meridian Bioscience
12.4.4.
Bio-Rad Laboratories
12.4.5.
Alpha Laboratories